Design, Synthesis and Biological Evaluation of Caffeic Acid Amides as Selective MMP-2 and MMP-9 Inhibitors

被引:12
|
作者
Shi, Zhi-Hao [1 ,3 ]
Li, Nian-Guang [1 ,2 ]
Shi, Qian-Ping [1 ,2 ]
Tang, Hao [1 ]
Tang, Yu-Ping [1 ]
Li, Wei [1 ,2 ]
Yin, Lian [1 ]
Yang, Jian-Ping [1 ]
Duan, Jin-Ao [1 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing 210046, Jiangsu, Peoples R China
[2] Nanjing Univ Chinese Med, Dept Med Chem, Nanjing 210046, Jiangsu, Peoples R China
[3] China Pharmaceut Univ, Dept Organ Chem, Nanjing 211198, Jiangsu, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
metrix metalloproteinase; caffeic acid; tumor; structure-activity relationship; MATRIX-METALLOPROTEINASE INHIBITOR; PHENETHYL ESTER; INTERSTITIAL COLLAGENASE; CATALYTIC DOMAIN; METASTASIS; CLEAVAGE; EXTRACT; DISEASE; ANALOGS; CANCER;
D O I
10.1002/ddr.21038
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Strategy, Management and Health Policy Preclinical Research A series of caffeic acid amides with extended P1' groups were synthesized and tested for their inhibitory activities on matrix metalloproteinase (MMP)-1, MMP-2, and MMP-9. Compound 3f showed considerable inhibitory activities against MMP-2, MMP-9, and best selectivity over MMP-1. Preliminary structureactivity relationship analysis and docking studies indicated that caffeic acid amides with electron-donating groups at p-position of amino phenyl group showed better inhibitory activities and selectivity than those with electron-withdrawing groups. The findings of this study would provide information for the exploitation and utilization of caffeic acid as MMP inhibitor for metastatic tumor treatment.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [1] Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies
    Das, Sanjib
    Amin, Sk Abdul
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [2] Visfatin Regulates MMP-2 and MMP-9
    Huang Fen
    Zhang Hao
    He Songzeng
    CIRCULATION, 2010, 122 (02) : E370 - E370
  • [3] MMP-2 and MMP-9 and Their Tissue Inhibitors in the Plasma of Preterm and Term Neonates
    Christina G Schulz
    Grzegorz Sawicki
    Robert P Lemke
    Birgitte M Roeten
    Richard Schulz
    Po-Yin Cheung
    Pediatric Research, 2004, 55 : 794 - 801
  • [4] MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates
    Schulz, CG
    Sawicki, G
    Lemke, RP
    Roeten, BM
    Schulz, R
    Cheung, PY
    PEDIATRIC RESEARCH, 2004, 55 (05) : 794 - 801
  • [5] Differential Vesicular Distribution and Trafficking of MMP-2, MMP-9, and Their Inhibitors in Astrocytes
    Sbai, Oualid
    Ould-Yahoui, Adlane
    Ferhat, Lotfi
    Gueye, Yatma
    Bernard, Anne
    Charrat, Eliane
    Mehanna, Ali
    Risso, Jean-Jacques
    Chauvin, Jean-Paul
    Fenouillet, Emmanuel
    Rivera, Santiago
    Khrestchatisky, Michel
    GLIA, 2010, 58 (03) : 344 - 366
  • [6] Regulation of MMP-2 and MMP-9 expression in childhood osteosarcoma by inducers and inhibitors
    Roomi, MW
    Ivanov, V
    Niedzwiecki, A
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 646 - 646
  • [8] Expression of MMP-2 and MMP-9 in retinoblastoma and their significance
    Long, Hua
    Zhou, Bo
    Jiang, Fa-Gang
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (05) : 489 - 491
  • [9] MMP-2、MMP-9与脑缺血
    赵刚
    李铁林
    中风与神经疾病杂志, 2001, (02) : 60 - 61
  • [10] Sodium Fluoride Inhibits MMP-2 and MMP-9
    Kato, M. T.
    Bolanho, A.
    Zarella, B. L.
    Salo, T.
    Tjaderhane, L.
    Buzalaf, M. A. R.
    JOURNAL OF DENTAL RESEARCH, 2014, 93 (01) : 74 - 77